at this point they need BS (and accounting shell games) to justify springing their trap....
their pre-market MARKET CAP built on price fixing and BS is 2,500 million
"Net product sales for the second-quarter ended June 30, 2013 were $6.5 million. For the first six months of 2013, net product sales totaled $7.7 million.
For the second-quarter ended June 30, 2013, net loss was $18.9 million, or $0.66 per share, compared with a net loss of $13.9 million, or $0.63 per share, for the same period in 2012. For the six months ended June 30, 2013, net loss was $37.0 million, or $1.30 per share, compared with a net loss of $25.6 million, or $1.18 per share, for the same period in 2012."
Your lack of foresight blinds you. You can justify your investment decisions however you wish, but it is all about the future.
It isn't price fixing, it isn't collusion, it isn't crooked, it is simply good business.
If you only look at the current value without any eye towards the future, that explains your losses.
I firmly believe that you won't admit you were wrong even when AEGR has 5,000 patients on their medication, all paid by insurance, and you will still claim it is a "scam" when in fact, it was simply your inability to see the potential.